|
KMID : 0383820120720020207
|
|
Tuberculosis and Respiratory Diseases
2012 Volume.72 No. 2 p.207 ~ p.211
|
|
|
A Case of Hemolytic Uremic Syndrome in a Lung Cancer Patient Treated with Gemcitabine
|
|
Pack Yun-Jung
Yang Keun-Suk
Jung Hong-Soon
Nam Hee-Chul
Jung Seung-Hye
Kim Boo-Gyoung
Kim Ka-Young
Kim Jeong-Ho
Kim Young-Ok
Yun Yu-Seon
|
|
|
Abstract
|
|
|
|
Hemolytic uremic syndrome (HUS) is a rare disorder characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. HUS arises from a wide spectrum of conditions, and chemotherapeutic agents have been reported to be associated with HUS, including Mitomycin, Cisplatin, Bleomycin, and Gemcitabine. A 76-year-old man treated with Gemcitabine due to non-small cell lung cancer developed clinical and laboratory findings compatible with HUS. Gemcitabine was ceased and hemodialysis and plasma exchange were utilized and he recovered. A high level of suspicion for HUS is necessary when cancer patients are treated with Gemcitabine, and prompt recognition and treatment are also essential.
|
|
|
KEYWORD
|
|
|
Hemolytic-Uremic Syndrome, Gemcitabine, Lung Neoplasms
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|